Thrivent Financial for Lutherans
IONS icon

Thrivent Financial for Lutherans’s Ionis Pharmaceuticals IONS Stock Holding History

Thrivent Financial for Lutherans’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$748K Hold
9,962
– – ﹤0.01% 2044
2025
Q4 		$788K Hold
9,962
– – ﹤0.01% 2067
2025
Q3 		$652K Buy
+9,962
New +$486K ﹤0.01% 1977
2023
Q3 		– Sell
-987,450
Closed -$40.5M – 2467
2023
Q2 		$40.5M Buy
987,450
+54,910
+6% +$2.11M 0.09% 275
2023
Q1 		$33.3M Buy
932,540
+13,208
+1% +$496K 0.08% 295
2022
Q4 		$34.7M Buy
919,332
+10,853
+1% +$456K 0.09% 282
2022
Q3 		$40.2M Sell
908,479
-368,304
-29% -$15.5M 0.11% 228
2022
Q2 		$47.3M Sell
1,276,783
-284,730
-18% -$10.7M 0.13% 209
2022
Q1 		$57.8M Buy
1,561,513
+27,514
+2% +$901K 0.11% 223
2021
Q4 		$46.7M Buy
1,533,999
+146,235
+11% +$4.6M 0.09% 263
2021
Q3 		$46.5M Buy
1,387,764
+1,264,397
+1,025% +$47.6M 0.09% 253
2021
Q2 		$4.92M Buy
123,367
+2,054
+2% +$80.5K 0.01% 927
2021
Q1 		$5.45M Buy
+121,313
New +$6.77M 0.01% 877
2017
Q4 		– Sell
-500
Closed -$25K – 2164
2017
Q3 		$25K Buy
+500
New +$26.2K ﹤0.01% 2061
2014
Q2 		– Sell
-150,200
Closed -$6.49M – 1722
2014
Q1 		$6.49M Buy
+150,200
New +$7.28M 0.04% 389

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans's IONS Position: Q1 2026 in Review

Thrivent Financial for Lutherans held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 9,962 shares worth $748K. The position accounts for ﹤0.01% of the portfolio, ranked #2044.

Thrivent Financial for Lutherans first reported a position in IONS in Q1 2014 and has held it in 15 quarters since. The position peaked at $57.8M in Q1 2022. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Thrivent Financial for Lutherans held 9,962 shares of Ionis Pharmaceuticals worth $748K as of Q1 2026.
  • Thrivent Financial for Lutherans left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #2044 holding.
  • Thrivent Financial for Lutherans first reported a position in Ionis Pharmaceuticals in Q1 2014 and has held it in 15 quarters since.
  • Thrivent Financial for Lutherans's Ionis Pharmaceuticals position peaked at $57.8M in Q1 2022.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.